Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Rifaximin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 233Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Bausch's Xifaxan Chosen For Inflation Reduction Act Medicare
    Bausch's Xifaxan Chosen For Inflation Reduction Act Medicare

    17 Jan 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/bausch-health-statement-on-selection-of-xifaxanrifaximin-for-inflation-reduction-acts-medicare-negotiation-program-969865

    ACCESSWIRE
    17 Jan 2025
    Share Share
    Amneal`s Generics Rifaximin Receives Tentative Approval in US
    Amneal`s Generics Rifaximin Receives Tentative Approval in US

    16 Jan 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218862

    FDA
    16 Jan 2025
    Share Share
    Supreme Court Declines Patent Dispute Over Bausch Diarrhea Drug
    Supreme Court Declines Patent Dispute Over Bausch Diarrhea Drug

    18 Nov 2024

    // REUTERS

    https://www.reuters.com/legal/us-supreme-court-declines-hear-patent-dispute-over-bausch-blockbuster-diarrhea-2024-11-18/

    REUTERS
    18 Nov 2024
    Share Share
    Bausch Health Brings Patent Infringement Lawsuit Against Norwich Pharmaceuticals
    Bausch Health Brings Patent Infringement Lawsuit Against Norwich Pharmaceuticals

    20 Jun 2024

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=879900&lang=en

    ACCESSWIRE
    20 Jun 2024
    Share Share
    Norwich Pharmaceuticals Generic Rifaximin Receives Tentative Approval in US
    Norwich Pharmaceuticals Generic Rifaximin Receives Tentative Approval in US

    20 Jun 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214369

    FDA
    20 Jun 2024
    Share Share
    Salix runs Xifaxan TV spot with 'Scandal' actor Bellamy Young
    Salix runs Xifaxan TV spot with 'Scandal' actor Bellamy Young

    10 May 2024

    // Nick Paul Taylor FIERCE PHARMA

    https://www.fiercepharma.com/marketing/salix-adds-melody-xifaxan-campaign-running-tv-spot-scandal-actor-bellamy-young

    Nick Paul Taylor FIERCE PHARMA
    10 May 2024
    Share Share